Corcept Therapeutics (CORT) Ownership
CORT$72.94-0.77 -1.04%
Market cap$7.98BEnterprise value$8.47BRevenue (TTM)$963.65MMarket position—
Score
66
Bullish
Value
54
Quality
59
Growth
84
Ownership data loads after the page opens.
Ownership data loads after the page opens.
CORT price $72.94 -0.77 -1.04%
Stocklytics score rationale: value 54, quality 59, growth 84.
AI Score 75. Corcept Therapeutics has a strong gross profit margin of approximately 75.6% and a net profit margin of about 16.8%, indicating solid profitability. However, its high price-to-earnings ratio of approximately 52.8 suggests that the stock may be overvalued relative to its earnings, despite a favorable growth outlook as reflected in its revenue growth in recent quarters
Insights · Forecast · Financials · Learn